Natalie C Edwards

Summary

Country: USA

Publications

  1. ncbi request reprint Cost-effectiveness model of long-acting risperidone in schizophrenia in the US
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, Massachusetts, USA
    Pharmacoeconomics 23:299-314. 2005
  2. doi request reprint The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, MA 01719, USA
    J Med Econ 15:623-34. 2012
  3. ncbi request reprint Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, MA 01719, USA
    Pharmacoeconomics 23:75-89. 2005
  4. ncbi request reprint One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, MA 01719, USA
    Curr Med Res Opin 24:3341-55. 2008

Detail Information

Publications4

  1. ncbi request reprint Cost-effectiveness model of long-acting risperidone in schizophrenia in the US
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, Massachusetts, USA
    Pharmacoeconomics 23:299-314. 2005
    ..The availability of a long-acting injection (LAI) formulation of risperidone may increase adherence and improve clinical and economic outcomes for people with schizophrenia...
  2. doi request reprint The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, MA 01719, USA
    J Med Econ 15:623-34. 2012
    ....
  3. ncbi request reprint Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, MA 01719, USA
    Pharmacoeconomics 23:75-89. 2005
    ..Long-acting risperidone may therefore be a cost saving therapeutic option for patients with schizophrenia...
  4. ncbi request reprint One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia
    Natalie C Edwards
    Health Services Consulting Corporation, Boxborough, MA 01719, USA
    Curr Med Res Opin 24:3341-55. 2008
    ....